EMEA-001203-PIP02-14-M02

Key facts

Active substance
Coagulation Factor VIIa (Recombinant)
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0214/2017
PIP number
EMEA-001203-PIP02-14-M02
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
  • Treatment of acquired haemophilia
  • Treatment of congenital coagulation disorders
Route(s) of administration
Intravenous use
Contact for public enquiries
LFB SA
France
Tel. +33 169827344
E-mail: nogierm@lfb.fr
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-001203-PIP02-14-M02
Compliance opinion date
04/09/2020
Compliance outcome
positive

Decision

How useful was this page?

Add your rating